FDA Inspection 884542 — Wuh-Liang Hwu, MD, PhD
The FDA completed an inspection of Wuh-Liang Hwu, MD, PhD on May 30, 2014 in Taipei. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- May 30, 2014
- Fiscal Year
- 2014
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Taipei (Taiwan)
Additional Details
Sponsor, Contract Research Organization